SKLB4771 (FLT3-IN-1)
CAS: 1370256-78-2
Ref. 3D-VEC25678
25mg | A consultar | ||
50mg | A consultar | ||
100mg | A consultar |
Información del producto
SKLB4771 (FLT3-IN-1) is a novel small molecule that has been synthesized to inhibit the activity of phosphoinositide 3-kinase (PI3K) and mammalian target of rapamycin (mTOR). It has shown efficacy in the treatment of cutaneous inflammation, atopic dermatitis, and psoriasis. SKLB4771 has also been shown to inhibit IL-10 production, which may be responsible for its anti-inflammatory effects. The mechanism of action is not yet fully understood but it is thought that SKLB4771 may work by inhibiting the production of MCP-1 and other inflammatory cytokines.
Propiedades químicas
Consulta técnica sobre: 3D-VEC25678 SKLB4771 (FLT3-IN-1)
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.